DeLucaGCEbersGCEsiriMM: Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts. Brain127: 1009–1018, 2004.
10.
GanterPPrinceCEsiriMM: Spinal cord axonal loss in multiple sclerosis: a post-mortem study. Neuropathol Appl Neurobiol25: 459–467, 1999.
11.
EvangelouNEsiriMMSmithS: Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol47: 391–395, 2000.
12.
TrappBDPetersonJRansohoffRM: Axonal transection in the lesions of multiple sclerosis. New Engl J Med338: 278–285, 1998.
KornekBStorchMKBauerJ: Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain124: 1114–1124, 2001.
15.
BitschASchuchardtJBunkowskiS: Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain123: 1174–1183, 2000.
16.
KornekBStorchMKWeissertR: Multiple sclerosis and chronic autoimmune encephalomyelitis. A comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol157: 267–276, 2000.
17.
KuhlmannTLingfeldGBitschA: Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain125: 2202–2212, 2002.
18.
WaxmanSGCranerMJBlackJA: Na(+) channel expression along axons in multiple sclerosis and its models. Trends Pharmacol Sci25: 584–591, 2004.
19.
CranerMJNewcombeJBlackJA: Molecular changes in neurons in multiple sclerosis: Altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchanger. Proc Natl Acad Sci U S A101: 8168–8173, 2004.
20.
KiddDBarkhofFMcConnellR: Cortical lesions in multiple sclerosis. Brain122: 17–26, 1999.
21.
BöLVedelerCANylandHI: Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol62: 723–732, 2003.
22.
BöLVedelerCANylandH: Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler9: 323–331, 2003.
23.
PetersonJWBöLMörkS: Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol50: 389–400, 2001.
24.
MeyerRWeissertRDiemR: Acute neuronal apoptosis in a rat model of multiple sclerosis. J Neurosci21: 6214–6220, 2001.
25.
ZhuBLuoLMooreGR: Dendritic and synaptic pathology in experimental autoimmune encephalomyelitis. Am J Pathol162: 1639–1650, 2003.
26.
CranerMJLoACBlackJA: Annexin II/p11 is upregulated in Purkinje cells in EAE and MS. Neuroreport14: 555–558, 2003.
27.
Rivera-QuinonesCMcGavernDSchmelzerJD: Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nature Med4: 187–193, 1998.
28.
MedanaIMartinicMAWekerleH: Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes. Am J Pathol159: 809–815, 2001.
29.
SmithKJKapoorRHallSM: Electrically active axons degenerate when exposed to nitric oxide. Ann Neurol49: 470–476, 2001.
30.
WernerPPittDRaineCS: Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol50: 169–180, 2001.
31.
GriffithsIKlugmannMAndersonT: Axonal swellings and degeneration in mice lacking the major proteolipidprotein of myelin. Science280: 1610–1613, 1998.
32.
GeorgeEBGlassJDGriffinJW: Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J Neurosci15: 6445–6452, 1995.
33.
GlassJDSchryerBLGriffinJW: Calcium-mediated degeneration of the axonal cytoskeleton in the Ola mouse. J Neurochem62: 2472–2475, 1994.
34.
KapoorRDaviesMBlakerPA: Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration. Ann Neurol53: 174–180, 2003.
35.
LoACBlackJAWaxmanSG: Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis. Neuroreport13: 1909–1912, 2002.
